Adverse events20

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 20

Type	Event	Organ system	Group	Affected	At risk
other	Gastrointestinal Disorders	Gastrointestinal disorders	Cisplatin Liposomal 24 mg/m2	2	7
other	Gastrointestinal Disorders	Gastrointestinal disorders	Cisplatin Liposomal 36 mg/m2	4	12
other	General Disorders and Admin Site Conditions	General disorders	Cisplatin Liposomal 24 mg/m2	1	7
other	General Disorders and Admin Site Conditions	General disorders	Cisplatin Liposomal 36 mg/m2	2	12
other	Respiratory, Thoracic and Mediastinal Disorders	Reproductive system and breast disorders	Cisplatin Liposomal 24 mg/m2	3	7
other	Respiratory, Thoracic and Mediastinal Disorders	Reproductive system and breast disorders	Cisplatin Liposomal 36 mg/m2	7	12
other	Nervous System Disorders	Nervous system disorders	Cisplatin Liposomal 24 mg/m2	1	7
other	Nervous System Disorders	Nervous system disorders	Cisplatin Liposomal 36 mg/m2	1	12
serious	Vomiting	Gastrointestinal disorders	Cisplatin Liposomal 24 mg/m2	1	7
serious	Vomiting	Gastrointestinal disorders	Cisplatin Liposomal 36 mg/m2	0	12
serious	pyrexia	General disorders	Cisplatin Liposomal 24 mg/m2	1	7
serious	pyrexia	General disorders	Cisplatin Liposomal 36 mg/m2	0	12
serious	dehydration	Metabolism and nutrition disorders	Cisplatin Liposomal 24 mg/m2	1	7
serious	dehydration	Metabolism and nutrition disorders	Cisplatin Liposomal 36 mg/m2	0	12
serious	musculoskeletal chest pain	Musculoskeletal and connective tissue disorders	Cisplatin Liposomal 24 mg/m2	0	7
serious	musculoskeletal chest pain	Musculoskeletal and connective tissue disorders	Cisplatin Liposomal 36 mg/m2	2	12
serious	Pleural effusion	Respiratory, thoracic and mediastinal disorders	Cisplatin Liposomal 24 mg/m2	0	7
serious	Pleural effusion	Respiratory, thoracic and mediastinal disorders	Cisplatin Liposomal 36 mg/m2	1	12
serious	Respiratory distress	Respiratory, thoracic and mediastinal disorders	Cisplatin Liposomal 24 mg/m2	0	7
serious	Respiratory distress	Respiratory, thoracic and mediastinal disorders	Cisplatin Liposomal 36 mg/m2	1	12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00102531/events

API reference For AI assistants